Clinical trials
Leukemia, Biphenotypic, Acute trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Children's Oncology Group | 1 |
| Dutch Childhood Oncology Group | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Kura Oncology, Inc. | 1 |
| Princess Maxima Center for Pediatric Oncology | 1 |
| Syndax Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Biphenotypic, Acute | 10 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 |
| Leukemia, Myeloid, Acute | 7 |
| Burkitt Lymphoma | 6 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Hodgkin Disease | 5 |
| Immunoblastic Lymphadenopathy | 5 |
| Immunoglobulin Light-chain Amyloidosis | 5 |
| Intraocular Lymphoma | 5 |
| Leukemia, Hairy Cell | 5 |
Trials
Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.